BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35921712)

  • 21. Deep learning-assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver.
    Oestmann PM; Wang CJ; Savic LJ; Hamm CA; Stark S; Schobert I; Gebauer B; Schlachter T; Lin M; Weinreb JC; Batra R; Mulligan D; Zhang X; Duncan JS; Chapiro J
    Eur Radiol; 2021 Jul; 31(7):4981-4990. PubMed ID: 33409782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-phase contrast-enhanced magnetic resonance image-based radiomics-combined machine learning reveals microscopic ultra-early hepatocellular carcinoma lesions.
    Sun K; Shi L; Qiu J; Pan Y; Wang X; Wang H
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2917-2928. PubMed ID: 35230493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a meta-analysis of eight prospective studies.
    Li J; Wang J; Lei L; Yuan G; He S
    Eur Radiol; 2019 Dec; 29(12):6519-6528. PubMed ID: 31250172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatocellular carcinoma segmentation and pathological differentiation degree prediction method based on multi-task learning].
    Wen H; Zhao Y; Yang Y; Wang H; Liu A; Yao Y; Fu Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2023 Feb; 40(1):60-69. PubMed ID: 36854549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters.
    Song D; Wang Y; Wang W; Wang Y; Cai J; Zhu K; Lv M; Gao Q; Zhou J; Fan J; Rao S; Wang M; Wang X
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3757-3767. PubMed ID: 33839938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical value of dual-energy computed tomography and diffusion-weighted imaging in the context of liver cancer: A narrative review.
    Fan PL; Chu J; Wang Q; Wang C
    J Clin Ultrasound; 2022 Jul; 50(6):862-868. PubMed ID: 35338779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LiverNet: efficient and robust deep learning model for automatic diagnosis of sub-types of liver hepatocellular carcinoma cancer from H&E stained liver histopathology images.
    Aatresh AA; Alabhya K; Lal S; Kini J; Saxena PUP
    Int J Comput Assist Radiol Surg; 2021 Sep; 16(9):1549-1563. PubMed ID: 34053009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of MRI and CT for the Prediction of Microvascular Invasion in Solitary Hepatocellular Carcinoma Based on a Non-Radiomics and Radiomics Method: Which Imaging Modality Is Better?
    Meng XP; Wang YC; Zhou JY; Yu Q; Lu CQ; Xia C; Tang TY; Xu J; Sun K; Xiao W; Ju S
    J Magn Reson Imaging; 2021 Aug; 54(2):526-536. PubMed ID: 33622022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gd-EOB-DTPA dynamic contrast-enhanced magnetic resonance imaging is more effective than enhanced 64-slice CT for the detection of small lesions in patients with hepatocellular carcinoma.
    Li J; Li X; Weng J; Lei L; Gong J; Wang J; Li Z; Zhang L; He S
    Medicine (Baltimore); 2018 Dec; 97(52):e13964. PubMed ID: 30593219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dictionary learning LASSO for feature selection with application to hepatocellular carcinoma grading using contrast enhanced magnetic resonance imaging.
    Lei L; Du LX; He YL; Yuan JP; Wang P; Ye BL; Wang C; Hou Z
    Front Oncol; 2023; 13():1123493. PubMed ID: 37091168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and
    Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
    World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomics-based classification of hepatocellular carcinoma and hepatic haemangioma on precontrast magnetic resonance images.
    Wu J; Liu A; Cui J; Chen A; Song Q; Xie L
    BMC Med Imaging; 2019 Mar; 19(1):23. PubMed ID: 30866850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MRI-based radiomics distinguish different pathological types of hepatocellular carcinoma.
    Wang X; Wang S; Yin X; Zheng Y
    Comput Biol Med; 2022 Feb; 141():105058. PubMed ID: 34836622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography.
    Min JH; Kim JM; Kim YK; Cha DI; Kang TW; Kim H; Choi GS; Choi SY; Ahn S
    Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2091-2100.e7. PubMed ID: 31843599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma.
    Chen CY; Chen J; Xia CC; Huang ZX; Song B
    J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint multiple fully connected convolutional neural network with extreme learning machine for hepatocellular carcinoma nuclei grading.
    Li S; Jiang H; Pang W
    Comput Biol Med; 2017 May; 84():156-167. PubMed ID: 28365546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-modality relationship constrained multi-modality multi-task feature selection for Alzheimer's Disease and mild cognitive impairment identification.
    Liu F; Wee CY; Chen H; Shen D
    Neuroimage; 2014 Jan; 84():466-75. PubMed ID: 24045077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.